A B S T R A C T Thyroid tissue obtained from 12 patients with Graves' disease and treated with thionamide drugs for 3-7 mo before subtotal thyroidectomy, from 12 patients with Graves' disease, similarly treated, and given 50 ,ug of triiodothyronine (T3) for 10 days before surgery, and from 12 euthyroid patients with solitary cold nodules was investigated to compare in vitro iodination of thyroglobulin in toxic diffuse goiter and in normal thyroid tissue. The supernates of the homogenates (105,000g) were subjected to sucrose density gradient centrifugation (5-28%) to separate the thyroglobulin fraction. The precipitates were treated with 1% digitonin and centrifuged to collect the supernate (particulate fraction). When thyroglobulin and particulate fractions obtained from the same patient were incubated with 125I-, iodide, glucose, and glucose oxidase, the amount of iodine bound to thyroglobulin was several times greater in toxic diffuse goiter than in normal thyroid tissue; administration of T3 did not affect iodination in toxic diffuse goiter. When the thyroglobulin fraction from each patient was incubated with a standardized quantity of peroxidase instead of the individual particulate fraction, the amount of iodine bound to thyroglobulin was the same among the three groups of patients. Finally, when bovine serum albumin was substituted for thyroglobulin from each of the patients, iodination of bovine serum albumin was several times greater with the particulate fraction obtained from toxic diffuse goiter tissue than with that obtained from normal
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INTRODUCTION

General procedure
Thyroid tissue obtained during surgery was quickly frozen and 500-mg aliquots were homogenized in 2.5 ml of cold saline in glass homogenizers at 1,000 rpm for 1 min. The homogenization was interrupted every 15 s to permit chilling of the homogenate for 10 s in ice water.
After 0.1 ml of the homogenate had been removed for DNA determinations, the homogenates were transferred to glass tubes and then centrifuged at 600 g for 10 min. 1-ml ali(quots of the supemates were transferred to polyearbonate tubes and diluted with 1 ml of saline, and additional 1-ml aliquots were transferred to cellulose nitrate tubes and diluted to 13.5 ml with saline. Ultracentrifugation of both dilutions was carried out for 30 min in a Beckman model L2-65B centrifuge with type 40 rotor (Beckman Instruments, Inc., Fullerton, Calif.), at a centrifugal force of 105,000g. The supernates of the former dilution were then frozen and stored for future isolation of thyroglobulin while the pellets were used for solubilizing peroxidase. The supernates of the latter dilution were discarded and the pellets were stored frozen for the determination of peroxidase activity by guaiacol-oxidizing activity.
Purification of thyroglobulin
Purification of thyroglobulin was carried out by sucrose density gradient centrifugation (1, 2). 0.3 ml of the 105,000g supemate was layered carefully on top of the sucrose gradient (5-28% in 0.05 M sodium phosphate buffer, pH 7.4) in a 5-ml Spinco tube (Beckman Instruments, Spinco Div., Palo Alto, Calif.), and centrifuged in the SW 50L rotor at 35,000 rpm for 15-16 h in a Beckman model L2-65B centrifuge.
After centrifugation, the bottom of the centrifuige tube was puncetured and consecutive 10-drop fractions were collected. After appropriate dilution, the total protein content of each fraction was determined by the method of Lowry et al. (3) . Fractions equivalent to 19S (determined using 131 I-labeled rat thyroglobulin) were pooled and diluted with phosphate buffer to a concentration of 1 nmol/0.2 ml. These fractions were used as the thyroglobulin fraction.
Solubilization of thyroid peroxidase
Solubilization of thyroid peroxidase was carried out by treatment with 1% digitonin (4, 5) . The 105,000g pellets were suispended with 0.8 ml of 0.05 M phosphate buffer, pH 7.0, containing 1% digitonin and were incubated for :30 inim in ice water before centrifugation at 105,000 g in polyearbonate tubes. The supernate of digitonin-treated pellets (which contains most of the peroxidase activity in thyroid tissue [6] ) was used without further purification.
In vitro iodination of thyroglobulin
In vitro iodination of thyroglobulin was carried out by a method similar to that described by Taurog (7) . The complete system for in vitro iodination of thyroglobulin consisted of the peroxidase fraction obtained from 50 mg of tissue, 1.0 nmol of thyroglobulin obtained from each patient, 10 nmol of Nal, 0.05 ,tCi of Na'251, 1.0 mg, of glucose, and 0.83 ,ug of glucose oxidase (G-6125, purified type II, 14 ,650 U/g solid, Sigma Chemical Co., St. Louis, Mo.) in a total volume of 1.0 ml of 0.05 M phosphate buffer, pH 7.0. Incubation was for 1 h at 37°C. At the end of incubation, 0.1 ml of 0.1 M methimazole was added to stop the reaction, and the separation of protein-bound and inorganic 1251 was carried out by paper chromatography in a butanolethanol-0.5 M ammonia system (5:1:2). Since thyroglobulin was purified by sucrose density gradient centrifugation, the thyroglobulin fraction contained high concentrations of sucrose. However, iodination of bovine serum albumin with lactoperoxidase was not affected by 0.25 M sucrose (unpublished data).
Assays of peroxidase activity lodinating activity. Activity of the peroxidase fraction was determined by the method used for in vitro iodination of thyroglobulin, except that 660 ,ug of bovine serum albumin was substituted for thyroglobulin as a standard protein to act as an iodine acceptor.
Guaiacol-oxidizing activity. The rate of oxidation of guaiacol was followed spectrophotometrically on a Beckman DB-G spectrophotometer at 470 nm (5, 6) . The 105,000 g pellet was suspended in 0.8 ml of 0.2 M phosphate buffer, pH 7.4, and 0.2 ml of the suspension, 1.0 ml of 0.1 M guaiacol, and 1.6 ml of phosphate buffer were mixed in a cuvette with a 1.0-cm light path, and the absorbance at 470 nm was set at zero. The reaction was begun with the addition of 10 ,ul of 88 mM H202, and the change in absorbance was recorded. The assay was performed at room temperature.
As had been reported previously (6) , the dose response curve of peroxidase is not linear and it is necessary to express peroxidase activity in terms of an equivalent amount of standard enzyme. The standard enzyme employed for the guaiacol assay was horse radish peroxidase (15,302, grade II, 100 U/mg, Boehringer Mannheim Corp., New York) and lactoperoxidase (L-8,503, 43 purpurogallin U/mg solid, Sigma Chemical Co.) for the iodinating activity assay.
Determination of DNA content in thyroid homogenates
The colorimetric estimation of DNA was carried out according to the method described by Burton (8) . 0.1 mnl of the homogenate was mixed with 4 ml of 0.5 N HCIO4 and centrifuged at 4°C after chilling for 30 min. The supernate was discarded and the precipitate was washed with 4 ml of HCl14. The precipitate was broken up with a glass rod and stirred with 3 ml of 0.5 N HC104, and the suspension was heated at 70°C for 15 min with occasional stirring. After cooling at room temperature, the stuspension was centrifuged for 30 min and 1 ml of the supernate was mixed with 2 ml of diphenylamine reagent containing acetaldehyde. Diphenylamine reagent was prepared by dissolving 1.5 g of diphenylamine (Koso Chemical Co. Ltd., Tokyo, Japan) in 100 ml of acetic acid and adding 1.5 ml of concentrated. H2SO4. On the day it is to be used, 0.1 ml of 16 mg/ml aqueous acetaldehyde was added for each 20 ml of reagent required. Tubes containing known amounts of standard DNA (highly polymerized calf thymus DNA, Sigma Chemical Co.) and a blank containing 0.5 N HC104 with no DNA were also 724 Nagataki, Uchinuiira, Ikecta, Kuzuiya, Ma.siyamra, Kuinagai, anid Ito 
RESULTS
In vitro iodination of thyroglobulin using the thyroglobulin and peroxidase fractions obtained from the same patients. In Table I Since the thyroglobulin and the peroxidase fractions in this system were obtained from the same patients, other experiments were carried out to determine which of the two fractions was responsible for the increase in iodination of thyroglobulin. In the following experiments, the results obtained from patients treated with methimazole are expressed as the means+SE, but the results from two patients treated with propylthiouracil are shown individually.
In vitro iodination of thyroglobulin using the thyroglobulin fraction from each patient and a standardized peroxidase. To elucidate whether the thyroglobulin fraction was responsible for the increased iodination of thyroglobulin, the system in this experiment consisted of thyroglobulin from each patient and a standardized quantity of peroxidase extracted from pooled thyroid tissue of patients with Graves' disease. As shown in Fig. 1 , there was no significant difference in iodination of thyroglobulin among the three groups of patients, indicating that the thyroglobulin fraction did not play a major role in increasing iodination in Graves' disease.
Peroxidase activity by the iodination assay. To observe the role of the peroxidase fraction, the system in this experiment consisted of the peroxidase fraction from each patient and bovine serum albumin which was substituted for thyroglobulin. This system was the same as that which was used in the method to determine peroxidase activity described by Taurog (7) . Values were expressed as peroxidase activity in terms of an equivalent amount of lactoperoxidase. Peroxidase activity in tissue obtained from patients with Graves' disease treated with methimazole was significantly greater than that found in normal thyroid tissue (P < 0.01 in micrograms lactoperoxidase per gram tissue, P < 0.02 in micrograms lactoperoxidase per milligram DNA). Values from patients treated with propylthiouracil were similar to those from methimazole-treated patients. Administration of T3 did not affect the peroxidase activity in Graves' disease regardless of whether the activity was expressed as micrograms of lactoperoxidase per gram thyroid tissue or per milligram of DNA (P > 0.05) (Fig. 2) . Therefore, the peroxidase fraction appears to be primarily responsible for increased iodination of thyroglobulin in Graves' disease.
Peroxidase activity by the guaiacol assay. Peroxidase activity in thyroid tissue was also determined by guaiacol-oxidizing activity, using horse radish peroxidase as standard enzyme. Similar to the iodinating activity, guaiacol-oxidizing activity in tissue obtained from patients with Graves' disease was significantly greater than that observed in normal tissue and the prior administration of T3 did not affect 726 Nagataki, Uchimura, Ikeda, Kuzuya, Masuyama, Kumagai, and Ito the activity. The difference was significant when guaiacol-oxidizing activity was expressed as micrograms of horse radish peroxidase per gram of tissue (P < 0.01) or per milligram of DNA (P < 0.05) (Fig. 3) .
DISCUSSION
In the present experiments, in vitro iodination of thyroglobulin using the thyroglobulin and peroxidase fractions obtained from the same patients was increased in Graves' disease even when patients were made euthyroid by treatment with thionamide drugs and also when an additional 50 gg of T3 was given for 10 days before surgery. These results agree well with the known increase in thyroid hormone synthesis in patients with Graves' disease and also with our previous finding that thyroidal 1311 uptakes remain elevated even when patients are made euthyroid by drug therapy (9) . The fact that iodinating activity of thyroid tissue was not affected by the administration of T3 is consistent with the T3 nonsuppressibility known to exist in vivo. In our experience, patients with Graves' disease continue to be nonsuppressible when treated with thionamide drugs for only 3-7 mo as were the patients in this study (9) . The increase in in vitro iodination of thyroglobulin is due mainly to an increase in peroxidase activity in the particulate fraction rather than to differences in the ease of iodination of thyroglobulin. Peroxidase activity should be decreased in the presence of antithyroid compounds whose mechanism of action is mainly blocking iodine organification. Whereas a direct effect of antithyroid drugs can not be ruled out, the peroxidase activity was not changed when rats were sacrificed 1 h after the injection of propylthiouracil (6), although methimazole may behave differently from propylthiouracil (10) . However, in the present experi- (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . In nontoxic nodular goiter, the activity is decreased in cold nodules and increased or remained the same as normal tissue in warm nodules (11, 12) . In goiters with an iodide organification defect, peroxidase activity is usually decreased (12) (13) (14) (15) (16) (17) , but is normal in Pendred's syndrome (18, 19) . Nontoxic multinodular goiter has increased peroxidase activity (19, 20) and it has been reported in a few patients with toxic diffuse goiter that peroxidase activity per gram tissue is increased much more than DNA content indicating that the activity per cell is increased (12, 19, 21 The administration of TSH stimulates thyroidal peroxidase activity in rats (6, 22, 23) ; however, the increase in peroxidase activity in thyroids of patients with Graves' disease is not due to an increase in serum TSH since TSH, T4, and T3 levels in the patients reported in this study were within the normal ranges and serum TSH concentrations were not detectable after the administration of T3.
In the present experiment, the formation of intrathyroidal iodothyronine was not measured, although thyroidal peroxidase stimulates not only the iodination of thyroglobulin, but also the formation of T4 (7, 24, 25) . The localization of peroxidase in thyroid cells is important in relation to its function (26) (27) (28) , but only values for total peroxidase activity in thyroid tissue were determined in the present study. It was reported that a small percentage of the total peroxidase activity was found in a fraction sedimenting at 600-1,000 g (5, 6, 14, 15) , but the 600-g pellet was discarded in this experiment. Furthermore, iodination of thyroglobulin was studied in vitro without turnover of substrates. Despite these points, it can be concluded that the increase in peroxidase activity is one of the essential changes within the thyroid which relates to the possible mechanism of increased thyroid hormone synthesis in Graves' disease. Evidence is currently available to suggest that an extrathyroidal stimulator (e.g. LATS [29] , LATS-protector [30, 31] , human thyroid stimulator [32] , thyroid-stimulating immunoglobulins [33] ) is indeed present in circulation of patients with Graves' disease. The extrathyroidal stimulator could cause increased peroxidase activity observed in this study. Other studies to detect an intrathyroidal defect in Graves' disease have failed to find the differences between thyroid tissue of normal controls and patients with Graves' disease, e.g. TSH stimulation of 32P incorporation into phospholipids (34) , basal adenyl cyclase, cyclic AMP concentrations, [1-14C] glucose oxidation, 32P incorporation or TSH-increased adenyl cyclase activity, and 32P incorporation (35) , intracellular binding characteristics of cyclic AMP (36) . However, it remains to be clarified whether the increase in peroxidase activity is due to an extrathyroidal stimulator or due to an intrathyroidal defect.
